City

Ann Arbor (1)

Gainesville (1)

New York (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Terminated (1)

Phase

n/a (1)

phase 2 (1)

Sponsor

Massive Bio, Inc. (1)

National Cancer Institute, Egypt (1)

SpeciCare (1)

University of Michigan Rogel Cancer Center (1)

Collaborator

Georgia Institute of Technology (1)

Netnoids (1)

Northeast Georgia Hospital System (1)

Predictive Oncology (1)

University of Washington (1)

Intervention

5-fluorouracil (1)

bupivacaine 0.25% (1)

cetuximab (1)

cisplatin (1)

clinical trial matching (1)

dexmedetomidine (1)

docetaxel (1)

thyroidectomy surgery (1)

ultrasound-guided intermediate cervical plexus block technique (1)

Study Documents

Individual Participant Data Set (1)

Informed Consent Form (1)

Study Protocol (1)

Intervention Type

drug (2)

other (1)

procedure (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (2)

Observational (1)

Observational [Patient Registry] (1)

cancer of larynx

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pain, Postoperative, Cancer of Larynx Trial (dexmedetomidine, bupivacaine 0.25%, Thyroidectomy Surgery)

Not yet recruiting

Pain, Postoperative
Cancer of Larynx

dexmedetomidine
+3 more

(no location specified)

Apr 14, 2023

Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

Recruiting

Cancer, Metastatic
+42 more

Clinical Trial Matching

New York, New York

Massive Bio, Inc

May 21, 2021

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo

Recruiting

Cancer, All Types
+44 more

Gainesville, Georgia

Specicare

Dec 2, 2020

Cancer of Larynx Trial in Ann Arbor (Cisplatin, Cetuximab, 5-Fluorouracil)

Terminated

Has Results

Cancer of Larynx

Cisplatin
+3 more

Ann Arbor, Michigan

University of Michigan Comprehensive Cancer Center

Nov 4, 2015